1. India Stocks

  2. •

    Process industries

  3. •

    Containers/Packaging
Bilcare Ltd

Bilcare Ltd

85.56
INR
-1.52
(-1.75%)
-5.65EPS
18.90P/E
1.47BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,300.47
1,143.46
1,103.86
1,118.24
1,177.53
1,270.25
773.73
260.96
353.78
409.7
313.59
329.62
306.87
328.39
Basic EPS, GAAP
-48.14
-91.76
-36.04
-35.9
-85.43
-193.28
-43.97
-8.95
-5.35
6.39
-14.12
-0.33
0.73
3.3
Free Cash Flow per Basic Share
-66.96
-133.85
-10.12
65.89
-49.25
38.33
108.8
27.93
15.53
-268.68
-24.32
27.11
49.68
- -
Dividend per Share
- -
- -
0.49
0.49
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
562.25
312.84
302.72
260.59
169.83
-29.66
45.99
36.66
31.91
225.37
89.59
90.98
83.55
- -
Tangible Book Value per Share
417.06
187.72
124.63
99.11
-9.51
-200.43
35.25
29.83
26.5
216.8
84.3
86.21
80.3
- -
Basic Weighted Avg Shares
24
24
24
24
24
24
24
24
24
24
24
24
24
24
Sales/Revenue/Turnover
30,620
26,923
25,991
26,329
27,725
29,908
18,218
6,144
8,330
9,646
7,384
7,761
7,225
7,730
Operating Margin (%)
3.34
-0.2
2.69
0.58
-8.11
-6.97
-10.51
1.4
2.54
2.05
-0.52
4.08
4.6
4.83
Depreciation Expense
3,229
32
1,636
1,769
4,162
3,784
2,388
455
393
378
449
181
198
331
Net Income, GAAP
-1,133
-2,160
-849
-845
-2,011
-4,551
-1,035
-211
-126
150
-332
-8
17
78
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
74.39
- -
- -
- -
- -
Profit Margin (%)
-3.7
-8.02
-3.26
-3.21
-7.25
-15.22
-5.68
-3.43
-1.51
1.56
-4.5
-0.1
0.24
1
Working Capital
10,582
4,002
1,487
432
-10,453
-11,870
540
239
180
46
611
33
611
- -
LT Debt
18,817
17,532
18,926
18,012
7,410
7,454
5,588
5,299
5,369
5,157
5,454
4,704
4,600
- -
Total Equity
13,764
7,940
7,716
6,760
4,633
-58
1,762
1,642
1,613
7,040
556
896
741
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
5.76
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.5
- -
- -
- -
- -
Return on Common Equity (%)
-8.56
-20.97
-11.71
-12.75
-39.69
- -
- -
-21.66
-15.6
4.97
-8.96
-0.37
0.84
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
1,604
- -
LT Borrowings
- -
4,497
- -
LT Finance Leases
- -
103
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
24
24
24
Market Capitalization
- -
- -
1,467

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
3,533
- -
Cash, Cash Equivalents & STI
- -
525
- -
Accounts Receivable, Net
- -
1,080
- -
Inventories
- -
1,148
- -
Total Current Liabilities
- -
2,922
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
1,604
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-299.65%
57.29%
-17.28%
Free Cash Flow
-308.77%
-418.75%
83.23%
Net Income, GAAP
-89.2%
-199.78%
-320.57%
Sales/Revenue/Turnover
-6.48%
5.23%
-6.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1,941
2,017
1,981
1,940
7,761
2026
1,864
1,782
1,813
1,877
7,225
2027
2,259
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-2.71
-6.81
-3.05
7.47
-0.33
2026
1.34
-5.25
-2.53
5.68
0.73
2027
5.39
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Mohan Harakechand Bhandari
Full Time Employees
54
Sector
Process industries
Industry
Containers/Packaging
Address
601, ICC Trade Tower Pune MA India 411016
IPO Date
Apr 25, 1995
Website
bilcare.com
Similar Companies
Segezha (MOEX:SGZH)
Amcor plc (NYSE:AMCR)
Duran Dogan Basim ve Ambalaj Sanayi A.S. (BIST:DURDO)
Isiklar Enerji ve Yapi Holding Anonim Sirketi (BIST:IEYHO)
PT Abadi Nusantara Hijau Investama Tbk (IDX:PACK)
UFlex Limited (NSE:UFLEX)
Business
Bilcare Limited (BI.BO), founded in 1987 and headquartered in Pune, India, operates as a holding company providing pharmaceutical packaging research solutions, global clinical services, research and development services, and anti-counterfeit technologies to the global pharmaceutical industry; its core products and services include specialty polymer films such as blister films, laminates, high-barrier products like Ultra Tx and Armour, and eco-friendly options like Optra; aluminum foils encompassing child-resistant (CR) foils, lidding foils, and blister foils; clinical trial supply management featuring manufacturing and packaging of investigational medicinal products (IMPs) and placebos, primary and secondary packaging with blinding techniques, interactive web response systems (IWRS), worldwide distribution, returns, and destructions; and R&D offerings such as formulation stability studies, blister/foil design and development, analytical research, packaging trials, pharmaceutical brand innovation, and market studies. The company serves pharmaceutical manufacturers worldwide across over 100 countries, with manufacturing facilities in Pune and Nashik boasting 50,000 tonnes annual capacity, ISO Class 8 clean rooms, and compliance with global standards including USFDA, EU Pharmacopoeia, USP 661.1, REACH, and DMF filings; it emphasizes its novel 5Cs approach—Convenience, Communication, Compliance, Child-Resistant, and Counterfeiting protection—delivered through barrier properties against moisture/light/gases, high-speed machinability, printability, and embedded security features. In March 2023, Bilcare completed a major strategic shift by transferring its pharmaceutical packaging innovation (PPI) business to Caprihans India Limited via a slump sale for Rs 213 crore in redeemable preference shares, enabling the company to become debt-free, reduce overheads, and refocus on high-growth areas including global clinical supplies, R&D services, and anti-counterfeit solutions like nonClonableID (nCID) technologies; this consolidation enhances synergies within the group while positioning Bilcare for improved profitability and global expansion in clinical services.